HOUSTON, Jan. 31, 2025 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (“IES”) (NASDAQ: IESC) announced that it has acquired Arrow Engine Company (“Arrow”), a Tulsa ...

In this article, we are going to take a look at where IES Holdings (NASDAQ:IESC) stands against the other stocks. Stock gains always get people talking, and 2025 is no exception. Markets have ...

IES Holdings, Inc. HOUSTON, Jan. 22, 2025 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced that it has amended and restated its existing ...

IES Holdings (IESC) has amended and restated its existing Credit and Security Agreement, increasing the commitment amount of the revolving credit facility to $300M from $150M and extending the ...

Credit: mi_viri/Shutterstock. Health Canada has granted market authorisation to Takeda Canada for FRUZAQLA (fruquintinib) capsules to treat adults with metastatic colorectal cancer (mCRC). The ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

TORONTO, Jan. 20, 2025 /CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that Health Canada has provided market authorization for FRUZAQLA ™ (fruquintinib capsules), indicated for the ...

with panitumumab (Vectibix, Amgen Inc.) for the treatment of certain adult patients with metastatic colorectal cancer (mCRC). Specifically, the combination therapy is indicated for those with KRAS ...

This was followed by positive reimbursement recommendations by Canada’s Drug Agency (CDA-AMC) and Institut national d’excellence en santé et services sociaux (INESSS). FRUZAQLA works by helping to ...